Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anette Veringa

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Antimicrobial Agents and Chemotherapy|February 3, 2016
Pharmacodynamics of Voriconazole in Children: Further Steps along the Path to True Individualized TherapyLuc J Huurneman, Michael Neely, Anette Veringa, et al.
Clinical and Translational Science|July 16, 2024
Inflammation altered correlation between CYP2C19 genotype and CYP2C19 activity in patients receiving voriconazoleSylvia D Klomp, Anette Veringa, Jan-Willem C Alffenaar, et al.
Journal of Clinical Medicine|June 2, 2021
Combined Impact of Inflammation and Pharmacogenomic Variants on Voriconazole Trough Concentrations: A Meta-Analysis of Individual DataLéa Bolcato, Charles Khouri, Anette Veringa, et al.
Current Fungal Infection Reports|July 1, 2016
Therapeutic Drug Monitoring of Posaconazole: an UpdateBart G J Dekkers, Martijn Bakker, Kim C M van der Elst, et al.
International Journal of Antimicrobial Agents|December 26, 2016
Bioavailability of voriconazole in hospitalised patientsAnette Veringa, Sanne Geling, Lambert F R Span, et al.
International Journal of Antimicrobial Agents|January 15, 2019
Posaconazole trough concentrations are not influenced by inflammation: A prospective studyAnne-Grete Märtson, Anette Veringa, Martijn Bakker, et al.
Mycoses|May 31, 2019
Posaconazole therapeutic drug monitoring in clinical practice and longitudinal analysis of the effect of routine laboratory measurements on posaconazole concentrationsAnne-Grete Märtson, Anette Veringa, Edwin R van den Heuvel, et al.
International Journal of Antimicrobial Agents|February 9, 2023
Voriconazole exposure is influenced by inflammation: A population pharmacokinetic modelD Abraham van den Born, Anne-Grete Märtson, Anette Veringa, et al.
Antimicrobial Agents and Chemotherapy|July 15, 2020
Caspofungin Weight-Based Dosing Supported by a Population Pharmacokinetic Model in Critically Ill PatientsAnne-Grete Märtson, Kim C M van der Elst, Anette Veringa, et al.
The Journal of Antimicrobial Chemotherapy|September 8, 2016
Voriconazole metabolism is influenced by severe inflammation: a prospective studyAnette Veringa, Mendy Ter Avest, Lambert F R Span, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Antimicrobial Agents and Chemotherapy|February 3, 2016
Pharmacodynamics of Voriconazole in Children: Further Steps along the Path to True Individualized TherapyLuc J Huurneman, Michael Neely, Anette Veringa, et al.
Clinical and Translational Science|July 16, 2024
Inflammation altered correlation between CYP2C19 genotype and CYP2C19 activity in patients receiving voriconazoleSylvia D Klomp, Anette Veringa, Jan-Willem C Alffenaar, et al.
Journal of Clinical Medicine|June 2, 2021
Combined Impact of Inflammation and Pharmacogenomic Variants on Voriconazole Trough Concentrations: A Meta-Analysis of Individual DataLéa Bolcato, Charles Khouri, Anette Veringa, et al.
Current Fungal Infection Reports|July 1, 2016
Therapeutic Drug Monitoring of Posaconazole: an UpdateBart G J Dekkers, Martijn Bakker, Kim C M van der Elst, et al.
International Journal of Antimicrobial Agents|December 26, 2016
Bioavailability of voriconazole in hospitalised patientsAnette Veringa, Sanne Geling, Lambert F R Span, et al.
International Journal of Antimicrobial Agents|January 15, 2019
Posaconazole trough concentrations are not influenced by inflammation: A prospective studyAnne-Grete Märtson, Anette Veringa, Martijn Bakker, et al.
Mycoses|May 31, 2019
Posaconazole therapeutic drug monitoring in clinical practice and longitudinal analysis of the effect of routine laboratory measurements on posaconazole concentrationsAnne-Grete Märtson, Anette Veringa, Edwin R van den Heuvel, et al.
International Journal of Antimicrobial Agents|February 9, 2023
Voriconazole exposure is influenced by inflammation: A population pharmacokinetic modelD Abraham van den Born, Anne-Grete Märtson, Anette Veringa, et al.
Antimicrobial Agents and Chemotherapy|July 15, 2020
Caspofungin Weight-Based Dosing Supported by a Population Pharmacokinetic Model in Critically Ill PatientsAnne-Grete Märtson, Kim C M van der Elst, Anette Veringa, et al.
The Journal of Antimicrobial Chemotherapy|September 8, 2016
Voriconazole metabolism is influenced by severe inflammation: a prospective studyAnette Veringa, Mendy Ter Avest, Lambert F R Span, et al.
Pageof 2